export default function PentagastrinOverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        Pentagastrin is a short synthetic peptide that was used as a diagnostic tool &mdash; it stimulates stomach acid production and triggers calcitonin release, which made it useful for two specific medical tests. It was never a treatment for anything. Genetic testing has largely replaced it in its main clinical application, and it&rsquo;s off the market in the US. This page exists for people researching GI or thyroid physiology, not because there&rsquo;s any community or enhancement use.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Curious Reader &mdash; researching stomach acid or thyroid biology</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I saw pentagastrin mentioned in a medical article about stomach acid testing &mdash; what is it and why don&rsquo;t doctors use it anymore?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re interested</p>
        <ol className="reta-overview__profile-why">
          <li><strong>It was a genuinely useful diagnostic tool</strong><br />Before modern genetic testing, pentagastrin was the standard way to detect early medullary thyroid cancer in families with hereditary risk. It triggered a measurable hormone response that revealed whether someone had early-stage disease. That was meaningful medicine at the time.</li>
          <li><strong>It connects to fundamental GI physiology</strong><br />Pentagastrin acts on the same receptor that gastrin &mdash; your stomach&rsquo;s own acid-secretion hormone &mdash; uses. Understanding pentagastrin means understanding how acid secretion is regulated, which connects to ulcers, Zollinger-Ellison syndrome, and proton pump inhibitor pharmacology.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">There is nothing to do with this information from a self-use perspective. Pentagastrin is a diagnostic agent that requires IV or subcutaneous injection in a monitored clinical setting, produces nausea and GI cramping, and has no duration of action beyond the test window. It went off the US market and its clinical role was replaced by genetic testing that&rsquo;s both safer and more informative. Net: historically important compound worth understanding, zero relevance for personal use of any kind.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The GI-Curious Person &mdash; digestive physiology, acid problems, enzyme testing</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;Could something like pentagastrin help with low stomach acid or digestive enzyme problems?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re interested</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Stomach acid and digestive enzymes are a real health concern</strong><br />Low stomach acid (hypochlorhydria) and pancreatic enzyme insufficiency are genuine medical problems that affect digestion. Someone researching these conditions might come across pentagastrin in the context of &ldquo;acid stimulation tests&rdquo; and wonder if it&rsquo;s relevant to their situation.</li>
          <li><strong>The gastrin pathway is foundational to understanding acid regulation</strong><br />Learning how pentagastrin works means learning how gastrin signals parietal cells to produce acid &mdash; the same pathway that proton pump inhibitors block. That&rsquo;s genuinely useful biology for understanding why certain medications work.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Pentagastrin is not a treatment for low stomach acid or digestive problems. It was used to measure acid production in one specific test context, not to restore or improve it therapeutically. Anyone with genuine concerns about stomach acid or pancreatic enzyme insufficiency has much better options: betaine HCl for symptomatic support, breath tests and actual enzyme panels for diagnosis, and clinician evaluation. Net: understanding pentagastrin clarifies how gastric physiology works, but it has no therapeutic relevance for digestive health.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The GI Physiology Biohacker &mdash; endocrinology history, receptor pharmacology</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;What&rsquo;s the pharmacology behind pentagastrin&rsquo;s dual use for both acid secretion testing and calcitonin stimulation? Why does a GI peptide trigger a thyroid hormone?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re interested</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The dual receptor story is genuinely interesting endocrinology</strong><br />Pentagastrin acts on the same receptor type (CCK-B/gastrin receptor) found on both stomach parietal cells and thyroid C cells. That one receptor class shows up in two very different tissues, explaining why pentagastrin could stimulate both maximal gastric acid output and calcitonin release &mdash; a real example of pleiotropic receptor expression in endocrinology.</li>
          <li><strong>It captures a pivotal moment in thyroid cancer diagnosis history</strong><br />The pentagastrin calcitonin stimulation test was the primary way to catch hereditary medullary thyroid cancer early in affected families during the 1980s and 90s. Following how this tool was developed, used, and then displaced by genetic testing is a case study in how medical diagnostics evolve.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">There is no enhancement, longevity, or performance application for pentagastrin &mdash; this is a strict reference compound. Its half-life is short, its effects are all adverse from a non-diagnostic perspective (nausea, cramping, flushing), and its only rational use was as a single-dose provocative test in a clinical setting. Calcium gluconate stimulation is now preferred where biochemical calcitonin testing is still needed; genetic testing has replaced it for most MEN2 family screening decisions. Net: valuable for understanding GI and thyroid endocrinology history, irrelevant for any personal use purpose.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What Pentagastrin is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>A therapeutic compound &mdash; it was exclusively a diagnostic agent with no treatment application</li>
              <li>Something with community use &mdash; there is none; this page is pharmacological reference only</li>
              <li>Available in the US market &mdash; it was withdrawn; calcium gluconate and genetic testing replaced it</li>
              <li>A treatment for low stomach acid, digestive problems, or any GI condition</li>
              <li>Relevant to any enhancement, recovery, or longevity goal</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>Historical importance in medullary thyroid cancer detection before genetic testing existed</li>
              <li>Illustrates how one receptor type (CCK-B/gastrin) appears in both stomach and thyroid tissue &mdash; a real endocrinology teaching case</li>
              <li>The gastric acid stimulation test helped characterize Zollinger-Ellison syndrome and hypergastrinemia</li>
              <li>A case study in how diagnostic tools get displaced by better technology</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
